Commercial intelligence infrastructure

Global bio-pharma decisions run on PharmSight

PharmSight connects data to decisions. With one partner, analytics, evidence, intelligence, and forecasts work from the same set of facts.

See how it works
Insight desk Example
  • Oncology forecastScenario model refreshed
    Updated
  • Neurology · MSCompetitor pipeline mapped
    Mapped
  • Immunology · RAHTA value dossier delivered
    Delivered
  • Launch excellenceField targeting confirmed
    Confirmed
500+projects delivered
100%client retention

Connect once. Reach every commercial team.

  • Brand teams
  • Market access
  • Medical affairs
  • BD & licensing
  • Field force
  • Portfolio strategy
  • HEOR teams
  • Launch teams

How it works

The layer beneath every commercial decision.

Between the data a company holds and the teams that act on it. We clean, connect, and interpret every input, and stand behind the answer.

  1. Data sources

    Sales, claims, real-world data, congress coverage, and pipeline feeds from every major market.

  2. PharmSight

    Technology, business, and therapy-area experts model, test, and explain the findings.

  3. Decision teams

    Out to brand, access, launch, and portfolio teams across the US, Europe, and beyond.

Built to scale

The infrastructure turning data into decisions across markets.

Service that sets the standard

Dedicated engagement leads and analysts stay with each client, so context carries from one project to the next.

  • Advanced AnalyticsLive
  • RWE & HEORLive
  • Competitive IntelligenceMonitoring
  • ForecastingLive
  • SuitesOn demand

Oncology

NSCLC, colorectal & urothelial cancer

Market models and competitor tracking for crowded tumour types.

Neurology

MS, Parkinson’s, epilepsy, ALS & Huntington’s

Patient journeys and access plans for long-term conditions.

Immunology

RA, IBD & Crohn’s, lupus & AS

Evidence and pricing work for biologic and biosimilar markets.

The most connected view of your market

75+Consultants
500+Projects
3Global hubs

Other areas

Haemophilia, diabetes, women’s health & more

Nephrology, endocrinology, and medical devices too.

AI tool · Decision Router

Route a question to the right answer.

Pick a goal and a market. The router traces how PharmSight would handle it, from sources to the team that receives the answer. It is a scripted example, not a live AI model.

Goal
Market
  1. SourcesClaims and epidemiology data
  2. PracticeForecasting
  3. ProductIntelliSight
  4. HubBoston, with Gurugram

First deliverable

An epidemiology-based market model with in-line and pipeline scenarios.

Typical first read-out

4–6 weeks (illustrative)

AI tool · Evidence Meter

How strong is the evidence behind your decision?

Move the sliders to show which inputs you already have. The meter estimates how firm a recommendation could be. Scores are illustrative.

56/100

Moderate evidence

Adding real-world data would make the strongest difference.

Products

Continuously developing, always ahead.

Cintel showing news, events, congress data, and analyst commentary

PS Intelligence

Cintel

News, events, congress coverage, analyst commentary, and historical sales in one place.

Conversity showing negotiation training modules

PS Training

Conversity

AI-powered negotiation and sales training for pricing and objection handling.

IntelliSight conversational analytics with a chart and chat panel

PS Analytics

IntelliSight

A conversational interface that lets business users question their data directly.

PS Lens

PharmLens

Part of the proprietary toolkit. A public product screen has not been released yet.

From Gurugram to Boston to Zug.

  • GurugramIndia · Delivery and analytics
  • BostonUnited States · Brand and access teams
  • ZugSwitzerland · European hub

Get in touch

Ready to be part of what’s next?

Brand lead, access team, or portfolio group: whoever you are in the commercial chain, PharmSight was built for you.

Let’s talk.

Leave your details and the PharmSight team will be in touch. This demo form stays in your browser.

Products interested in